Old Web
English
Sign In
Acemap
>
authorDetail
>
Penelope J. Bristow
Penelope J. Bristow
Medicine
Testosterone
Clinical trial
Prednisone
Oncology
2
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Clinical activity and safety of ASN001, a selective CYP17 lyase inhibitor, administered without prednisone in men with metastatic castration-resistant prostate cancer (mCRPC).
2017
Journal of Clinical Oncology
Jorge A. Garcia
Robert Dreicer
Allan J. Pantuck
Naomi B. Haas
Ulka N. Vaishampayan
Drew W. Rasco
Allison Janine Tyler
Niranjan Sathyanarayana Rao
Penelope J. Bristow
Sanjeeva Reddy
Louis Denis
Anthony W. Tolcher
Show All
Source
Cite
Save
Citations (0)
ASN002: A Potent Dual SYK/JAK Inhibitor Currently in a Phase I/II Study Shows Strong Antitumor Activity in Preclinical Studies
2015
Blood
Niranjan S. Rao
Sanjeeva Reddy
Gupta Sandeep
Nitin K. Damle
Venkatesan M Aranapakam
Scott B. Thompson
Roger A. Smith
Terry Plasse
Penelope J. Bristow
Anthony W. Tolcher
Kyriakos P. Papadopoulos
Amita Patnaik
Drew W. Rasco
Show All
Source
Cite
Save
Citations (2)
1